-
Something wrong with this record ?
Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
S. Skolekova, M. Matuskova, M. Bohac, L. Toro, E. Durinikova, S. Tyciakova, L. Demkova, J. Gursky, L. Kucerova,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
BioMedCentral
from 2003-12-01
BioMedCentral Open Access
from 2003
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-08-01
Open Access Digital Library
from 2003-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
Springer Nature OA/Free Journals
from 2003-12-01
- MeSH
- Apoptosis drug effects MeSH
- Drug Resistance, Neoplasm MeSH
- Cisplatin pharmacology MeSH
- Interleukin-6 immunology MeSH
- Interleukin-8 immunology MeSH
- Humans MeSH
- Mesenchymal Stem Cells cytology drug effects immunology MeSH
- Cell Line, Tumor MeSH
- Tumor Microenvironment drug effects MeSH
- Breast Neoplasms drug therapy immunology MeSH
- Antineoplastic Agents pharmacology MeSH
- Breast drug effects immunology MeSH
- Cellular Senescence drug effects MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Cells of the tumor microenvironment are recognized as important determinants of the tumor biology. The adjacent non-malignant cells can regulate drug responses of the cancer cells by secreted paracrine factors and direct interactions with tumor cells. RESULTS: Human mesenchymal stromal cells (MSC) actively contribute to tumor microenvironment. Here we focused on their response to chemotherapy as during the treatment these cells become affected. We have shown that the secretory phenotype and behavior of mesenchymal stromal cells influenced by cisplatin differs from the naïve MSC. MSC were more resistant to the concentrations of cisplatin, which was cytotoxic for tumor cells. They did not undergo apoptosis, but a part of MSC population underwent senescence. However, MSC pretreatment with cisplatin led to changes in phosphorylation profiles of many kinases and also increased secretion of IL-6 and IL-8 cytokines. These changes in cytokine and phosphorylation profile of MSC led to increased chemoresistance and stemness of breast cancer cells. CONCLUSION: Taken together here we suggest that the exposure of the chemoresistant cells in the tumor microenvironment leads to substantial alterations and might lead to promotion of acquired microenvironment-mediated chemoresistance and stemness.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000658
- 003
- CZ-PrNML
- 005
- 20170116094142.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12964-016-0127-0 $2 doi
- 024 7_
- $a 10.1186/s12964-016-0127-0 $2 doi
- 035 __
- $a (PubMed)26759169
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Skolekova, Svetlana $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. svetlana.skolekova@savba.sk.
- 245 10
- $a Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells / $c S. Skolekova, M. Matuskova, M. Bohac, L. Toro, E. Durinikova, S. Tyciakova, L. Demkova, J. Gursky, L. Kucerova,
- 520 9_
- $a BACKGROUND: Cells of the tumor microenvironment are recognized as important determinants of the tumor biology. The adjacent non-malignant cells can regulate drug responses of the cancer cells by secreted paracrine factors and direct interactions with tumor cells. RESULTS: Human mesenchymal stromal cells (MSC) actively contribute to tumor microenvironment. Here we focused on their response to chemotherapy as during the treatment these cells become affected. We have shown that the secretory phenotype and behavior of mesenchymal stromal cells influenced by cisplatin differs from the naïve MSC. MSC were more resistant to the concentrations of cisplatin, which was cytotoxic for tumor cells. They did not undergo apoptosis, but a part of MSC population underwent senescence. However, MSC pretreatment with cisplatin led to changes in phosphorylation profiles of many kinases and also increased secretion of IL-6 and IL-8 cytokines. These changes in cytokine and phosphorylation profile of MSC led to increased chemoresistance and stemness of breast cancer cells. CONCLUSION: Taken together here we suggest that the exposure of the chemoresistant cells in the tumor microenvironment leads to substantial alterations and might lead to promotion of acquired microenvironment-mediated chemoresistance and stemness.
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a prsy $x účinky léků $x imunologie $7 D001940
- 650 _2
- $a nádory prsu $x farmakoterapie $x imunologie $7 D001943
- 650 _2
- $a stárnutí buněk $x účinky léků $7 D016922
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a cisplatina $x farmakologie $7 D002945
- 650 _2
- $a chemorezistence $7 D019008
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interleukin-6 $x imunologie $7 D015850
- 650 _2
- $a interleukin-8 $x imunologie $7 D016209
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $x účinky léků $x imunologie $7 D059630
- 650 _2
- $a nádorové mikroprostředí $x účinky léků $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Matuskova, Miroslava $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. miroslava.matuskova@savba.sk.
- 700 1_
- $a Bohac, Martin $u Department of Plastic, Aesthetic and Reconstructive Surgery, University Hospital, Bratislava, Slovakia. bohac.md@gmail.com.
- 700 1_
- $a Toro, Lenka $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. exonbara@savba.sk.
- 700 1_
- $a Durinikova, Erika
- 700 1_
- $a Tyciakova, Silvia
- 700 1_
- $a Demkova, Lucia $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. lucia.demkova@savba.sk.
- 700 1_
- $a Gursky, Jan $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 5, Olomouc, Czech Republic. jan.gursky@upol.cz.
- 700 1_
- $a Kucerova, Lucia $u Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Vlarska 7, 833 91, Bratislava, Slovakia. lucia.kucerova@savba.sk.
- 773 0_
- $w MED00008216 $t Cell communication and signaling CCS $x 1478-811X $g Roč. 14, č. - (2016), s. 4
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26759169 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170116094247 $b ABA008
- 999 __
- $a ok $b bmc $g 1179798 $s 961225
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 14 $c - $d 4 $e 20160112 $i 1478-811X $m Cell communication and signaling $n Cell Commun Signal $x MED00008216
- LZP __
- $a Pubmed-20170103